Form 8-K - Current report:
SEC Accession No. 0001615774-17-006627
Filing Date
2017-11-14
Accepted
2017-11-14 09:00:51
Documents
3
Period of Report
2017-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s108165_8k.htm 8-K 15059
2 EXHIBIT 99.1 s108165_ex99-1.htm EX-99.1 89763
3 GRAPHIC img001_v1.jpg GRAPHIC 9852
  Complete submission text file 0001615774-17-006627.txt   119599
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 171198613
SIC: 2834 Pharmaceutical Preparations